C9422 Cytarabine - CanMED: HCPCS

Main Menu

Main Menu

• Home
• Cancer Statistics
  • Cancer Statistics
  • Reports on Cancer
  • Annual Report to the Nation on the Status of Cancer
  • Cancer Stat Facts
  • Preliminary Cancer Incidence Rates and Trends
  • SEER Publications
  • Interactive Tools, Maps, & Graphs
  • Cancer Statistics Explorer Network
  • Cancer Query System
  • Understanding Statistics
  • Did You Know? Video Series
  • Defining Cancer Statistics
  • Glossary of Statistical Terms
• SEER Data & Software
  • SEER Data & Software
  • SEER Incidence Database
  • Comparison of Data Products
  • How to Request the Data
  • Documentation for Data
  • SEER*Stat Database Details
  • Variable and Recode Definitions
  • U.S. Datasets
  • U.S. Mortality
  • U.S. Populations
  • Standard Populations
  • SEER Linked Databases
  • Statistical Software
  • SEER*Stat
  • SEER*Prep
  • Methods & Tools for Population-based Cancer Statistics
• Registry Operations
  • Registry Operations
  • Reporting Guidelines
  • SEER Program Coding Manual
  • Hematopoietic Project
  • Solid Tumor Rules
  • Tools & Software
  • Glossary for Registrars
  • SEER*Rx - Drug Database
  • SEER Abstracting Tool
  • SEER Data Management System (SEER*DMS)
  • Staging
  • Registrar Staging Assistant (SEER*RSA)
  • Summary Stage 2018
  • Staging Resources
  • Extent of Disease 2018
  • Pediatric Data Collection System and Staging Manual
  • Questions & Answers
  • SEER Inquiry System
  • Ask a SEER Registrar
  • Data Collection Answers
  • Cancer PathCHART
  • Training
• News & Events
• About SEER
  • About SEER
  • Program Overview
  • Goals of the SEER Program
  • Fact Sheets & Brochures
  • Collaborating Organizations
  • SEER Registries
  • What is a Cancer Registry?
  • List of Registries
  • Registry Groupings
  • Population Characteristics
  • Research Activities
  • Residual Tissue Repository Program
  • SEER-Linked Virtual Tissue Repository Program
  • SEER Quality Improvement

Home SEER Data & Software Observational Research in Oncology Toolbox CanMED: HCPCS Medication Information CanMED and the Oncology Toolbox

CanMED: HCPCS

• About
• NDC
• HCPCS

Generic Name: Cytarabine Brand Name: Cytarabine Strength: 100 mg HCPCS: C9422 SEER*Rx Category: Chemotherapy Major Drug Class: Antimetabolite Minor Drug Class: Pyrimidine Analog Oral (Y/N): No FDA Approval Year: 1998 FDA Discontinuation Year: CMS Effective Date: Jan. 1, 2004 CMS Discontinuation Date: Dec. 31, 2005 Status: No Longer Used